Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors

Ming Fu Chiang, Shur Tzu Chen, Chen Peng Lo, Chun-I Sze, Nan-Shan Chang, Yu Jen Chen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background AND ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products. methods: Immunohistochemistry, western blotting and in situ hybridization were used for WOX1 protein and WWOX mRNA expression. Immunofluorescence and electron microscopical immunohistochemistry were performed for colocalization of gene products. RESULTS: WOX1 expression is low in normal cortical neurons, mainly on the axon fibers, whereas there is moderate to high immunoreactivity in the cytosol and nuclei of certain tumor cells. In the microcystic (WHO grade I) and malignant (WHO grade III) meningiomas, WOX1 expression is intense, but various in transitional (WHO grade I) and atypical (WHO grade II) subtypes. WOX1 levels are moderate to high in the menigiotheliomatous area, but relatively low in the fibroblastic area. WOX1 and NF2/merlin, but not p53, colocalized in certain tumor cells, primarily at the borders of nuclei. Schwannoma and astrocytoma specimens stained moderately to strongly positive for the WOX1 protein. Interestingly, the expression of WOX1, NF2/merlin and mutant p53 is intense in high grade glioblastoma, but WOX1 expression is low in metastatic carcinoma or adenocarcinoma. CONCLUSIONS: The expression of WOX1 on different types of nervous system tumors, including primary and metastatic tumors, is differential.

Original languageEnglish
Pages (from-to)133-147
Number of pages15
JournalAnalytical Cellular Pathology
Volume36
Issue number5-6
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Neurofibromin 2
Nervous System Neoplasms
Neurofibromatosis 2
Oxidoreductases
Neoplasms
Immunohistochemistry
Neurilemmoma
Astrocytoma
Meningioma
Glioblastoma
Tumor Suppressor Genes
Cytosol
In Situ Hybridization
Fluorescent Antibody Technique
Axons
Proteins
Adenocarcinoma
Western Blotting
Electrons
Carcinoma

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Cell Biology
  • Cancer Research

Cite this

Chiang, Ming Fu ; Chen, Shur Tzu ; Lo, Chen Peng ; Sze, Chun-I ; Chang, Nan-Shan ; Chen, Yu Jen. / Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors. In: Analytical Cellular Pathology. 2013 ; Vol. 36, No. 5-6. pp. 133-147.
@article{ececc100bad342febc56d6cdecaf067f,
title = "Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors",
abstract = "Background AND ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products. methods: Immunohistochemistry, western blotting and in situ hybridization were used for WOX1 protein and WWOX mRNA expression. Immunofluorescence and electron microscopical immunohistochemistry were performed for colocalization of gene products. RESULTS: WOX1 expression is low in normal cortical neurons, mainly on the axon fibers, whereas there is moderate to high immunoreactivity in the cytosol and nuclei of certain tumor cells. In the microcystic (WHO grade I) and malignant (WHO grade III) meningiomas, WOX1 expression is intense, but various in transitional (WHO grade I) and atypical (WHO grade II) subtypes. WOX1 levels are moderate to high in the menigiotheliomatous area, but relatively low in the fibroblastic area. WOX1 and NF2/merlin, but not p53, colocalized in certain tumor cells, primarily at the borders of nuclei. Schwannoma and astrocytoma specimens stained moderately to strongly positive for the WOX1 protein. Interestingly, the expression of WOX1, NF2/merlin and mutant p53 is intense in high grade glioblastoma, but WOX1 expression is low in metastatic carcinoma or adenocarcinoma. CONCLUSIONS: The expression of WOX1 on different types of nervous system tumors, including primary and metastatic tumors, is differential.",
author = "Chiang, {Ming Fu} and Chen, {Shur Tzu} and Lo, {Chen Peng} and Chun-I Sze and Nan-Shan Chang and Chen, {Yu Jen}",
year = "2013",
month = "1",
day = "1",
doi = "10.3233/ACP-140087",
language = "English",
volume = "36",
pages = "133--147",
journal = "Analytical Cellular Pathology",
issn = "2210-7177",
publisher = "IOS Press",
number = "5-6",

}

Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors. / Chiang, Ming Fu; Chen, Shur Tzu; Lo, Chen Peng; Sze, Chun-I; Chang, Nan-Shan; Chen, Yu Jen.

In: Analytical Cellular Pathology, Vol. 36, No. 5-6, 01.01.2013, p. 133-147.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors

AU - Chiang, Ming Fu

AU - Chen, Shur Tzu

AU - Lo, Chen Peng

AU - Sze, Chun-I

AU - Chang, Nan-Shan

AU - Chen, Yu Jen

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background AND ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products. methods: Immunohistochemistry, western blotting and in situ hybridization were used for WOX1 protein and WWOX mRNA expression. Immunofluorescence and electron microscopical immunohistochemistry were performed for colocalization of gene products. RESULTS: WOX1 expression is low in normal cortical neurons, mainly on the axon fibers, whereas there is moderate to high immunoreactivity in the cytosol and nuclei of certain tumor cells. In the microcystic (WHO grade I) and malignant (WHO grade III) meningiomas, WOX1 expression is intense, but various in transitional (WHO grade I) and atypical (WHO grade II) subtypes. WOX1 levels are moderate to high in the menigiotheliomatous area, but relatively low in the fibroblastic area. WOX1 and NF2/merlin, but not p53, colocalized in certain tumor cells, primarily at the borders of nuclei. Schwannoma and astrocytoma specimens stained moderately to strongly positive for the WOX1 protein. Interestingly, the expression of WOX1, NF2/merlin and mutant p53 is intense in high grade glioblastoma, but WOX1 expression is low in metastatic carcinoma or adenocarcinoma. CONCLUSIONS: The expression of WOX1 on different types of nervous system tumors, including primary and metastatic tumors, is differential.

AB - Background AND ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products. methods: Immunohistochemistry, western blotting and in situ hybridization were used for WOX1 protein and WWOX mRNA expression. Immunofluorescence and electron microscopical immunohistochemistry were performed for colocalization of gene products. RESULTS: WOX1 expression is low in normal cortical neurons, mainly on the axon fibers, whereas there is moderate to high immunoreactivity in the cytosol and nuclei of certain tumor cells. In the microcystic (WHO grade I) and malignant (WHO grade III) meningiomas, WOX1 expression is intense, but various in transitional (WHO grade I) and atypical (WHO grade II) subtypes. WOX1 levels are moderate to high in the menigiotheliomatous area, but relatively low in the fibroblastic area. WOX1 and NF2/merlin, but not p53, colocalized in certain tumor cells, primarily at the borders of nuclei. Schwannoma and astrocytoma specimens stained moderately to strongly positive for the WOX1 protein. Interestingly, the expression of WOX1, NF2/merlin and mutant p53 is intense in high grade glioblastoma, but WOX1 expression is low in metastatic carcinoma or adenocarcinoma. CONCLUSIONS: The expression of WOX1 on different types of nervous system tumors, including primary and metastatic tumors, is differential.

UR - http://www.scopus.com/inward/record.url?scp=84903304172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903304172&partnerID=8YFLogxK

U2 - 10.3233/ACP-140087

DO - 10.3233/ACP-140087

M3 - Article

VL - 36

SP - 133

EP - 147

JO - Analytical Cellular Pathology

JF - Analytical Cellular Pathology

SN - 2210-7177

IS - 5-6

ER -